We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF

41 hedge funds and large institutions have $84.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

348% more capital invested

Capital invested by funds: $18.8M → $84.4M (+$65.6M)

163% more call options, than puts

Call options by funds: $246M | Put options by funds: $93.4M

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

6.56% more ownership

Funds ownership: 0.11%6.67% (+6.6%)

13% less funds holding

Funds holding: 4741 (-6)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
0.6%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
11
Reduced
7
Closed
22
Calls
$246M
Puts
$93.4M
Net Calls
+$153M
Net Calls Change
+$156M

LABU Hedge Fund Activity: Q4 2023 in Review

41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2023, worth a combined $84.4M — up 348% from $18.8M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LABU and 18 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Barclays, opening a new position worth an estimated $11.6M. The largest seller was HRT Financial, exiting entirely with an estimated $1.94M sold.

  • 41 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2023, down from 47 in Q3 2023.
  • Funds reported $84.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2023, up 348% quarter-over-quarter.
  • 18 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2023 and 22 closed out, a net change of -4 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2023 was Barclays, an estimated $11.6M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2023 was HRT Financial, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2023.